PB1772: HIGH SLIT2 LEVELS ARE ASSOCIATED WITH GMP LIKE AML AND TREATMENT WITH RECOMBINANT SLIT2 INHIBITS LEUKEMOGENESIS

• Luise Araujo de Albuquerque Simoes,
• Isabel Weinhäuser,
• Diego Antonio Pereira-Martins,
• Cesar Alexander Ortiz Rojas,
• Lucio Henrique Pinheiro,
• Thiago Mantello Bianco,
• Rita de Cassia Cavaglieri,
• Eduardo Magalhaes Rego

Affiliations

Luise Araujo de Albuquerque Simoes

1 Faculty of Medicine of The University of São Paulo, Hematology, São Paulo, Brazil

Isabel Weinhäuser

3 Center for Cell Based Therapy, Fundação Hemocentro de Ribeirão Preto, Ribeirão Preto, Brazil

Diego Antonio Pereira-Martins

3 Center for Cell Based Therapy, Fundação Hemocentro de Ribeirão Preto, Ribeirão Preto, Brazil

Cesar Alexander Ortiz Rojas

3 Center for Cell Based Therapy, Fundação Hemocentro de Ribeirão Preto, Ribeirão Preto, Brazil

Lucio Henrique Pinheiro

1 Faculty of Medicine of The University of São Paulo, Hematology, São Paulo, Brazil

Thiago Mantello Bianco

3 Center for Cell Based Therapy, Fundação Hemocentro de Ribeirão Preto, Ribeirão Preto, Brazil

Rita de Cassia Cavaglieri

4 Medical Research Laboratory on Molecular Hematology (LIM31), São Paulo, Brazil

Eduardo Magalhaes Rego

1 Faculty of Medicine of The University of São Paulo, Hematology, São Paulo, Brazil